Adoptive Cell Therapy Long-term Follow-up (LTFU) Study

ClinicalTrials.gov ID: NCT03391778

Public ClinicalTrials.gov record NCT03391778. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 21, 2026, 9:30 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Long-Term Follow-Up (LTFU) of Participants Treated With ADP Adoptive Cell Therapies

Study identification

NCT ID: NCT03391778
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 1
Lead sponsor: USWM CT, LLC; Industry
Enrollment: 250 participants

Conditions and interventions

Conditions

Neoplasms

Interventions

ADP adoptive cell therapy Biological

Biological

Eligibility (public fields only)

Age range: Not listed
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Apr 8, 2018
Primary completion: Mar 31, 2032
Completion: Mar 31, 2032
Last update posted: Mar 2, 2026

2018 – 2032

United States locations

U.S. sites: 13
U.S. states: 10
U.S. cities: 13

Facility	City	State	ZIP	Site status
Emory University School of Medicine	Atlanta	Georgia	30322	Recruiting
ADP Investigational Site	Baltimore	Maryland	21201	Recruiting
National Cancer Institute - Center for Cancer Research	Bethesda	Maryland	20892	Completed
University of Michigan	Ann Arbor	Michigan	48109	Recruiting
Washington University School of Medicine in St. Louis	St Louis	Missouri	63110	Recruiting
Memorial Sloan Kettering Cancer Center - New York	New York	New York	10065	Recruiting
Duke University Medical Center	Durham	North Carolina	27710	Recruiting
Oregon Health and Science University	Portland	Oregon	97239	Recruiting
University of Pennsylvania	Philadelphia	Pennsylvania	19104	Recruiting
University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center	Pittsburgh	Pennsylvania	15232	Recruiting
University of Texas Southwestern Medical Center	Dallas	Texas	75390	Recruiting
University of Texas MD Anderson Cancer Center	Houston	Texas	77030	Recruiting
Froedtert Hospital	Milwaukee	Wisconsin	53226	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 11 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT03391778, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Mar 2, 2026 · Synced Jul 21, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03391778 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →